Biotechnology Value Fund L P's Form 4 filing
XOMA Royalty Corp (XOMA) · filed Sep 27, 2022
- Accession no.
- 0000921895-22-002715
- Filed
- Sep 27, 2022, 7:22 PM ET
- Trade date
- Sep 23-27, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $409.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Director, 10% Owner |
| BVF Partners L PCIK 0001055947 | Director, 10% Owner, Other: See Remarks |
| BVF IncCIK 0001056807 | Director, 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Director, 10% Owner |
| Lampert Mark NCIK 0001233840 | Director, 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Director, Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Director, Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | Director, 10% Owner |
| BVF II GP LLCCIK 0001803806 | Director, 10% Owner |
| BVF GP Holdings LLCCIK 0001803809 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +6,715 | $16.50 | +$110,777.36 | 1,780,495 | Direct | |
| Sep 26, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +3,339 | $16.83 | +$56,201.05 | 1,783,834 | Direct | |
| Sep 27, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +1,004 | $16.89 | +$16,957.76 | 1,784,838 | Direct | |
| Sep 23, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +9,885 | $16.50 | +$163,072.85 | 1,597,695 | Direct | |
| Sep 26, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +3,021 | $16.83 | +$50,848.57 | 1,600,716 | Direct | |
| Sep 27, 2022 | Common Stock, $0.0075 par value per share | PPurchaseAcquired | +678 | $16.89 | +$11,451.56 | 1,601,394 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.